Just want to let you guys know it's not going to stop at 8...........I expect that it will hit 10 buy August......phase III results will be released and it will either crash and burn or continue to ride up......I don't see how the results can hinder their growth.
As a medical professional, I've researched the pharmacodynamics of this drug. It has tremendous, tremendous potential to reinvent the way diabetes is treated.
FDA shot it down last time because of the delivery device which I thought wasn't prudent. The efficacy of the inhalation insulin is unparalleled compared to it's IV counterpart. In addition, it's plasma half life is faster than it's IV competitor so essentially you get a drug that works quickly and leaves quickly. It will decrease hypoglycemic risk 10 fold.
I hate falling in love with a company and a stock but I'm glad I got in at $6.50.
This post was edited on 6/11 at 11:02 am